Delayed Closure in Colorectal Surgery May Not Cut Infections
Delayed primary closure with intrawound irrigation doesn’t reduce surgical site infections after colorectal perforation.
Newsletter
Intestine and Lower Gastrointestinal Tract
Every new paper in this field, in your inbox.
Pelvic MRI is unreliable post-neoadjuvant therapy for rectal cancer.
Surgeons should be cautious in relying solely on MRI for treatment decisions following total neoadjuvant therapy, as endoscopic CCR does not guarantee a lack of disease.
Cost-Effective Strategies in Complicated Diverticulitis
Early colectomy is more cost-effective than interval colectomy for managing complicated diverticulitis with abscesses, leading to better outcomes for patients.
Adhesion Barriers Cut Small-Bowel Obstruction After Ladd Procedure
Using adhesion barriers during the Ladd procedure reduces rehospitalization for small-bowel obstruction without raising midgut volvulus risk.
New Colorectal Cancer Staging Improves Survival Predictions
The AJCC's proposed 9th edition colorectal cancer staging could enhance survival stratification for patients, affecting treatment decisions.
Diverticulitis Admissions Show Seasonal Patterns Worldwide
Diverticulitis incidence peaks in warmer months, highlighting potential environmental triggers.
Neoadjuvant Chemo Fails to Improve Outcomes in Colorectal Metastases
Neoadjuvant chemotherapy before CRS/HIPEC for metachronous colorectal peritoneal metastases offers no survival benefit and increases complication risks.
Total Neoadjuvant Therapy Hurts Survival in Rectal Cancer
Patients with rectal cancer who undergo total neoadjuvant therapy have significantly worse survival rates after liver surgery.
Predictive Model for Perineural Invasion in Colorectal Cancer
A new predictive score identifies patients at risk for perineural invasion (PNI) in colorectal cancer, impacting surgical management and outcomes.
Lower cCR rates in cT4 rectal cancer after total neoadjuvant therapy.
Patients with cT4 tumors show significantly lower chances of achieving a complete clinical response (cCR) compared to those with cT3.